HScore在检测COVID-19继发性噬血细胞性淋巴组织细胞增生症中的应用有限。 - Suppr | 超能文献

Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19.

作者信息

Sangha Gina, Kaushik Kunaal, Robinson Amelia, Ainge Thomas, Dungarwalla Moez, Chakraborty Arup

机构信息

Oxford University Hospital NHS Foundation Trust, Oxford, UK.

Milton Keynes University Hospital, Milton Keynes, UK.

出版信息

Br J Haematol. 2021 Aug;194(4):686-688. doi: 10.1111/bjh.17533. Epub 2021 May 16.

DOI:10.1111/bjh.17533

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19.HScore在检测COVID-19继发性噬血细胞性淋巴组织细胞增生症中的应用有限。

Br J Haematol. 2021 Aug;194(4):686-688. doi: 10.1111/bjh.17533. Epub 2021 May 16.

2

Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: response.HScore在检测COVID-19继发噬血细胞性淋巴组织细胞增生症中的应用有限：回应

Br J Haematol. 2021 Aug;194(4):688-689. doi: 10.1111/bjh.17535. Epub 2021 May 16.

3

Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019.评估 COVID-19 患者的噬血细胞性淋巴组织细胞增生症 H 评分。

Clin Infect Dis. 2021 Nov 2;73(9):e3110-e3112. doi: 10.1093/cid/ciaa1463.

4

Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality.住院 COVID-19 患者中由改良 H 评分提示的二级噬血细胞性淋巴组织细胞增生症不常见，高分与死亡率增加无关。

Clin Med (Lond). 2021 Sep;21(5):e543-e547. doi: 10.7861/clinmed.2021-0053. Epub 2021 Aug 13.

5

Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID-19.继发性噬血细胞性淋巴组织细胞增生症在新冠肺炎癌症患者中较为罕见。

Br J Haematol. 2021 Feb;192(3):e87-e90. doi: 10.1111/bjh.17275. Epub 2020 Dec 16.

6

Haemophagocytic lymphohistiocytosis in an adult with postacute COVID-19 syndrome.成人新冠感染后(postacute COVID-19)综合征相关噬血细胞性淋巴组织细胞增生症。

BMJ Case Rep. 2021 Sep 13;14(9):e245031. doi: 10.1136/bcr-2021-245031.

7

Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore.COVID-19 相关噬血细胞性淋巴组织细胞增生症：骨髓噬血细胞现象的 HScore 与尸检结果的相关性。

J Clin Pathol. 2022 Jun;75(6):383-389. doi: 10.1136/jclinpath-2020-207337. Epub 2021 Mar 15.

8

The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.在未进行骨髓活检的情况下计算的继发性噬血细胞性淋巴组织细胞增生症的HScore，在新冠肺炎患者中一直较低。

Int J Lab Hematol. 2020 Dec;42(6):e270-e273. doi: 10.1111/ijlh.13310. Epub 2020 Aug 10.

9

[Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].[新型冠状病毒肺炎中的继发性噬血细胞性淋巴组织细胞增生症和细胞因子释放综合征，是同一实体还是不同实体？]

Rev Chilena Infectol. 2021 Apr;38(2):271-278. doi: 10.4067/S0716-10182021000200271.

10

Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.噬血细胞性淋巴组织细胞增生症：COVID-19 大流行引发的综述。

Rheumatol Int. 2021 Jan;41(1):7-18. doi: 10.1007/s00296-020-04636-y. Epub 2020 Jun 25.

引用本文的文献

1

Hemophagocytic lymphohistiocytosis diagnosed by bone marrow trephine biopsy in living post-COVID-19 patients: case report and mini-review.COVID-19 后生存患者经骨髓活检诊断噬血细胞性淋巴组织细胞增生症：病例报告及迷你综述。

J Mol Histol. 2022 Aug;53(4):753-762. doi: 10.1007/s10735-022-10088-4. Epub 2022 Jun 14.